Cite
Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease.
MLA
Arunsurat, Itthiphat, et al. “Outcome of Pulse Oral Cyclophosphamide Therapy in Scleroderma Interstitial Lung Disease.” Clinical Rheumatology, vol. 40, no. 1, Jan. 2021, pp. 205–11. EBSCOhost, https://doi.org/10.1007/s10067-020-05217-x.
APA
Arunsurat, I., Mahakkanukrauh, A., Foocharoen, C., Suwannaroj, S., & Nanagara, R. (2021). Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease. Clinical Rheumatology, 40(1), 205–211. https://doi.org/10.1007/s10067-020-05217-x
Chicago
Arunsurat, Itthiphat, Ajanee Mahakkanukrauh, Chingching Foocharoen, Siraphop Suwannaroj, and Ratanavadee Nanagara. 2021. “Outcome of Pulse Oral Cyclophosphamide Therapy in Scleroderma Interstitial Lung Disease.” Clinical Rheumatology 40 (1): 205–11. doi:10.1007/s10067-020-05217-x.